Official UK procurement notice
Cytation 9 Imager and 406 FX Washer/Reagent Dispenser
Authority: University Of Edinburgh (Education)
What is being bought
Published requirement descriptionCytation 9 Imager and 406 FX Washer/Reagent Dispenser
CPV: Laboratory, optical and precision equipments (excl. glasses)
The lotProcurement structure
single lot · no lot value publishedLot #1We are awarding a contract to Agilent Technologies LDA UK Limited for the purchase of…
We are awarding a contract to Agilent Technologies LDA UK Limited for the purchase of the Cytation 9 Imager and the 406 FX Washer/Reagent Dispenser based on their ability to meet specific technical and operational requirements.
The Edinburgh Genome Foundry is undergoing major expansion to incorporate a fully automated platform for the handling and analysis of mammalian cells. For a piece of kit to be integrated in such an automated platform, it needs to be designed especially for this purpose.
The Agilent Cytation 9 combines high-content imaging, multimode microplate reading, and both upright and inverted microscopy within a single instrument.
The Agilent BioTek 406 FX also combines automated washing and reagent dispensing capabilities, together with built-in ultrasonic maintenance technology (key for fully automated operations) within a single integrated system. This is a unique combination of capabilities that would otherwise require multiple instruments.
It is necessary for these instruments to perform multiple functions due to essential requirement to fit a robotic platform in a limited space and therefore it is not possible to have separate standalone instruments performing each function. The Agilent solutions provide the required functionality while maintaining the performance standards necessary for advanced cell-based assay workflows.
Furthermore, the Cytation 9 and 406 FX are designed to operate as complementary components within automated cell-based assay workflows. This integrated workflow enables efficient end-to-end automation, reduces manual intervention, and supports the facility's requirement for high-throughput, reproducible operation. The facility also collaborates extensively with international Biofoundries and partner laboratories that utilise the same platform. Adoption of this equipment will facilitate collaboration, enable the exchange of validated protocols and data, and support standardisation of workflows across laboratories, which is a key requirement within Engineering Biology.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 11 Jun 2026, 15:13 BST
- Last source update
- 11 Jun 2026, 15:13 BST
- Authority reference
DA0473- FTS notice number
2026/S 000-055331- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-06b335Find a Tender
- Why no open competition
- The procurement falls outside the scope of application of the directive
- Published justification
After comprehensive market engagement, competition is absent for technical reasons. No reasonable alternative or substitute exists and the absence of competition is not the result of an artificial narrowing down of the parameters of the procurement.
This notice is the final piece of due diligence prior to the award of the contract. Should a supplier detail their ability to meet the requirements, then the award will be halted.
Publisher note: (SC Ref:834473)
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Agilent Technologies LDA UK Ltd | £195,000 † | — | Awarded |
Contracts
Contract 055331-2026-DA0473-1 · Agilent Technologies LDA UK Ltd
- Signed
- 11 Jun 2026
- Value
- £195,000
- Status
- active
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Edinburgh Sheriff CourtReview body
Bidders & participating suppliers
1 commercial party on the notice- Agilent Technologies LDA UK LtdAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.